Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar;13(3):232-242.
doi: 10.1111/1753-0407.13108. Epub 2020 Sep 14.

Glycemic control and risk factors for in-hospital mortality and vascular complications after coronary artery bypass grafting in patients with and without preexisting diabetes

Affiliations

Glycemic control and risk factors for in-hospital mortality and vascular complications after coronary artery bypass grafting in patients with and without preexisting diabetes

Yanyan Chen et al. J Diabetes. 2021 Mar.

Abstract

Background: The purpose of this study was to investigate risk factors of in-hospital mortality and vascular complications after coronary artery bypass grafting (CABG), particularly the effect of different glycemic control levels on outcomes in patients with and without previous evidence of diabetes.

Methods: A total of 8682 patients with and without previous diabetes undergoing CABG were categorized into strict, moderate, and liberal glucose control groups according to their mean blood glucose control level <7.8 mmol/L, 7.8 to 10.0 mmol/L, and ≥10.0 mmoL/L after in-hospital CABG.

Results: The patients with previous diabetes had higher rates of in-hospital mortality (1.3% vs 0.4%, P < .001) and major complications (7.0% vs 4.8%, P < .001) than those without diabetes. Current diabetes was significantly associated with a higher risk of in-hospital mortality (odds ratio [OR] = 3.14, 95% confidence interval [CI] 1.87-5.27) and major complications (OR = 1.49, 95% CI 1.24-1.80), and smoking and higher low-density lipoprotein cholesterol (LDL-C) levels showed similar results. Among patients with previous diabetes, strict glucose control was significantly associated with an increased risk of in-hospital mortality (OR = 8.32, 95% CI 3.95-17.51) compared with moderate glucose control. Nevertheless, among non-previous diabetic patients with stress hyperglycemia, strict glucose control led to a lower risk of major complications (OR = 0.71, 95% CI 0.52-0.98).

Conclusions: Diabetes status, smoking, and LDL-C levels were modifiable risk factors of both in-hospital mortality and major complications after CABG. Strict glucose control was associated with an increased risk of in-hospital mortality among patients with diabetes, whereas it reduced the risk of major complications among non-previous diabetic patients.

目的: 探讨冠状动脉旁路移植术患者院内死亡和血管并发症的影响因素, 重点分析不同血糖控制水平对有, 无糖尿病史患者术后并发症的影响。 方法: 8682名接受冠状动脉旁路移植术治疗患者依术后平均血糖控制水平分为严格, 中度和宽松血糖控制三个组。各组平均血糖值依次为<7.8mmol/L, 7.8-10.0mmol/L和≥10.0mmoL/L。 结果: 有糖尿病史的患者院内死亡率及术后主要并发症明显高于无糖尿病史患者(院内死亡率:1.3% vs 0.4%, P <0 .001; 主要并发症:7.0% vs 4.8%, P <0 .001)。糖尿病状态显著增加院内死亡风险(OR:3.14, 95%CI:1.87-5.27)和主要并发症风险(OR = 1.49, 95%CI 1.24-1.80); 吸烟及低密度脂蛋白胆固醇升高亦增加死亡和主要并发症风险。在有糖尿病史患者中, 与中度血糖控制组相比, 严格血糖控制组院内死亡风险明显增加(OR:8.32, 95% CI:3.95-17.51)。与之相反, 在无糖尿病史患者中, 严格血糖控制组的主要并发症风险却明显减少(OR:0.71,95% CI:0.52-0.98)。 结论: 糖尿病, 吸烟和低密度脂蛋白胆固醇升高是冠状动脉旁路移植术后院内死亡和主要并发症的三个可变危险因素。严格血糖控制增加糖尿病手术患者院内死亡风险, 但却可以减少非糖尿病患者术后主要并发症风险。.

Keywords: complications; coronary artery bypass grafting; diabetes; mortality; risk factor; 冠状动脉旁路移植术; 危险因素; 并发症; 死亡率; 糖尿病.

PubMed Disclaimer

Conflict of interest statement

The authors have no potential conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Patient flowchart. BG, blood glucose; CABG, coronary artery bypass graft
FIGURE 2
FIGURE 2
Outcomes rates after coronary artery bypass grafting by glycemic control level for patients without and with diabetes. A, In‐hospital mortality. B, Major complications. Major complications included acute myocardial infarction, acute stroke, or acute renal failure. P is for the comparison with the moderate control group. Strict control: mean blood glucose <7.8 mmol/L; moderate control: mean blood glucose 7.8‐10.0 mmol/L; and liberal control: mean blood glucose ≥10.0 mmol/L
FIGURE 3
FIGURE 3
Adjusted odds ratios for the relationships between glucose control and in‐hospital mortality and major complications. Propensity score‐weighted multivariable logistic regression was used with adjusting for age, sex, smoking, systolic blood pressure, low‐density lipoprotein cholesterol, chronic renal failure, congestive heart failure, previous myocardial infarction, combined valve surgery, and extracorporeal circulation. A, In‐hospital mortality. B, Major complications. Squares represent odds ratios of in‐hospital mortality, triangles represent odds ratios of major complications. Horizontal bars represent 95% confidence intervals. CI indicates confidence interval

Similar articles

Cited by

References

    1. Weisel RD, Nussmeier N, Newman MF, et al. Predictors of contemporary coronary artery bypass grafting outcomes. J Thorac Cardiovasc Surg. 2014;148(6):2720‐2726. - PubMed
    1. Velazquez EJ, Lee KL, Deja MA, et al. Coronary‐artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364:1607‐1616. - PMC - PubMed
    1. Yoo JS, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW. Coronary artery bypass grafting in patients with left ventricular dysfunction: predictors of long‐term survival and impact of surgical strategies. Int J Cardiol. 2013;168:5316‐5322. - PubMed
    1. Kunadian V, Zaman A, Qiu W. Revascularization among patients with severe left ventricular dysfunction: a meta‐analysis of observational studies. Eur J Heart Fail. 2011;13:773‐784. - PMC - PubMed
    1. Holly TA, Bonow RO, Arnold JM, et al. Myocardial viability and impact of surgical ventricular reconstruction on outcomes of patients with severe left ventricular dysfunction undergoing coronary artery bypass surgery: results of the surgical treatment for ischemic heart failure trial. J Thorac Cardiovasc Surg. 2014;148:2677‐2684. - PMC - PubMed

MeSH terms